Log in to save to my catalogue

Targeting GOF p53 and c-MYC through LZK Inhibition or Degradation Suppresses Head and Neck Tumor Gro...

Targeting GOF p53 and c-MYC through LZK Inhibition or Degradation Suppresses Head and Neck Tumor Gro...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3130983160

Targeting GOF p53 and c-MYC through LZK Inhibition or Degradation Suppresses Head and Neck Tumor Growth

About this item

Full title

Targeting GOF p53 and c-MYC through LZK Inhibition or Degradation Suppresses Head and Neck Tumor Growth

Publisher

United States: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2024-11

Language

English

Formats

Publication information

Publisher

United States: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

The worldwide frequency of head and neck squamous cell carcinoma (HNSCC) is approximately 800,000 new cases, with 430,000 deaths annually. We determined that LZK (encoded by
) is a therapeutic target in HNSCC and showed that inhibition with small molecule inhibitors decreases the viability of HNSCC cells with amplified
. A drug-resistant muta...

Alternative Titles

Full title

Targeting GOF p53 and c-MYC through LZK Inhibition or Degradation Suppresses Head and Neck Tumor Growth

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_3130983160

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3130983160

Other Identifiers

ISSN

2692-8205

E-ISSN

2692-8205

DOI

10.1101/2024.11.19.623840